Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Vet Res ; 54(1): 59, 2023 Jul 13.
Article in English | MEDLINE | ID: mdl-37443113

ABSTRACT

Most drugs used in the treatment of helminthiasis in humans and animals have lost their efficacy due to the development of drug-resistance in helminths. Moreover, since anthelmintics, like many pharmaceuticals, are now recognized as hazardous contaminants of the environment, returning to medicinal plants and their products represents an environmentally friendly way to treat helminthiasis. The goal of the present study was to test the anthelminthic activity of methanol extracts of eight selected European ferns from the genera Dryopteris, Athyrium and Blechnum against the nematode Haemonchus contortus, a widespread parasite of small ruminants. Eggs and adults of H. contortus drug-susceptible strain ISE and drug-resistant strain WR were isolated from experimentally infected sheep. The efficacy of fern extracts was assayed using egg hatch test and adults viability test based on ATP-level measurement. Among the ferns tested, only Dryopteris aemula extract (0.2 mg/mL) inhibited eggs hatching by 25% in comparison to control. Athyrium distentifolium, Dryopteris aemula and Dryopteris cambrensis were effective against H. contortus adults. In concentration 0.1 mg/mL, A. distentifolium, D. aemula, D. cambrensis significantly decreased the viability of females from ISE and WR strains to 36.2%, 51.9%, 32.9% and to 35.3%, 27.0%, 23.3%, respectively in comparison to untreated controls. None of the extracts exhibited toxicity in precise cut slices from ovine liver. Polyphenol's analysis identified quercetin, kaempferol, luteolin, 3-hydroxybenzoic acid, caffeic acid, coumaric acid and protocatechuic acid as the major components of these anthelmintically active ferns.


Subject(s)
Anthelmintics , Ferns , Haemonchus , Helminthiasis , Sheep Diseases , Veterinary Drugs , Humans , Sheep , Animals , Plant Extracts/pharmacology , Veterinary Drugs/pharmacology , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Larva , Sheep Diseases/drug therapy , Sheep Diseases/parasitology
2.
Vet Res ; 52(1): 124, 2021 Sep 30.
Article in English | MEDLINE | ID: mdl-34593042

ABSTRACT

The parasitic gastrointestinal nematode Haemonchus contortus causes serious economic losses to agriculture due to infection and disease in small ruminant livestock. The development of new therapies requires appropriate viability testing, with methods nowadays relying on larval motility or development using procedures that involve microscopy. None of the existing biochemical methods, however, are performed in adults, the target stage of the anthelmintic compounds. Here we present a new test for the viability of H. contortus adults and exsheathed third-stage larvae which is based on a bioluminescent assay of ATP content normalized to total protein concentration measured using bicinchoninic acid. All the procedure steps were optimized to achieve maximal sensitivity and robustness. This novel method can be used as a complementary assay for the phenotypic screening of new compounds with potential antinematode activity in exsheathed third-stage larvae and in adult males. Additionally, it might be used for the detection of drug-resistant isolates.


Subject(s)
Adenosine Triphosphate/therapeutic use , Haemonchiasis/veterinary , Haemonchus/isolation & purification , Luminescent Measurements/veterinary , Molecular Diagnostic Techniques/veterinary , Sheep Diseases/diagnosis , Animals , Female , Haemonchiasis/diagnosis , Haemonchiasis/parasitology , Haemonchus/growth & development , Larva/growth & development , Luminescent Measurements/instrumentation , Male , Molecular Diagnostic Techniques/instrumentation , Sheep , Sheep Diseases/parasitology , Sheep, Domestic
3.
Food Chem Toxicol ; 129: 382-390, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31059744

ABSTRACT

Vaccinium myrtillus L. (bilberry) fruit is a blue-colored berry with a high content of anthocyanins. These bioactive secondary metabolites are considered to play a major role in the health-promoting properties of bilberries. Our in vivo study was designed to assess the possible influence of bilberry extract on drug-metabolizing enzymes (DMEs). Rats were exposed to bilberry extract in drinking water at two concentrations (0.15 and 1.5 g/L). Selected DMEs were determined (mRNA expression and enzymatic activity) after 29 and 58 days in rat liver. In addition, a panel of antioxidant, physiological, biochemical and hematological parameters was studied; these parameters did not demonstrate any impact of bilberry extract on the health status of rats. A significant increase in activity was observed in cytochrome P450 (CYP) 2C11 (131% of control) and CYP2E1 (122% of control) after a 29-day administration, while the consumption of a higher concentration for a longer time led to a mild activity decrease. Slight changes were observed in some other DMEs, but they remained insignificant from a physiological perspective. According to our results, we conclude that the consumption of bilberries as a food supplement should not pose a risk of interacting with co-administered drugs based on their metabolism.


Subject(s)
Cytochrome P-450 Enzyme System/drug effects , Plant Extracts/pharmacology , Vaccinium myrtillus/chemistry , Animals , Antioxidants/pharmacology , Cytochrome P-450 Enzyme System/metabolism , Male , Rats , Rats, Wistar
4.
Parasit Vectors ; 12(1): 191, 2019 Apr 30.
Article in English | MEDLINE | ID: mdl-31039802

ABSTRACT

BACKGROUND: Due to anthelmintic resistance problems, there is a need to discover and develop new drugs for the treatment and control of economically important and pathogenic nematodes of livestock animals. With this focus in mind, we screened 236 compounds from a library (called the 'Kurz-box') representing chemically diverse classes such as heterocyclic compounds (e.g. thiazoles, pyrroles, quinolines, pyrimidines, benzo[1,4]diazepines), hydoxamic acid-based metalloenzyme inhibitors, peptidomimetics (bis- and tris-pyrimidoneamides, alkoxyamides) and various intermediates on Haemonchus contortus, one of the most important parasitic nematodes of ruminants. METHODS: In the present study, we tested these compounds, and measured the inhibition of larval motility and development of exsheathed third-stage (xL3) and fourth-stage (L4) larvae of H. contortus using an optimised, whole-organism phenotypic screening assay. RESULTS: Of the 236 compounds, we identified two active compounds (called BLK127 and HBK4) that induced marked phenotypic changes in the worm in vitro. Compound BLK127 induced an 'eviscerated' phenotype in the xL3 stage and also inhibited L4 development. Compound HBK4 exerted a 'curved' phenotype in both xL3s and L4s. CONCLUSIONS: The findings from this study provide a basis for future work on the chemical optimisation of these compounds, on assessing the activity of optimised compounds on adult stages of H. contortus both in vitro and in vivo (in the host animal) and against other parasitic worms of veterinary and medical importance.


Subject(s)
Anthelmintics/pharmacology , Haemonchus/growth & development , Animals , Anthelmintics/chemistry , Drug Evaluation, Preclinical , Female , Haemonchus/drug effects , Inhibitory Concentration 50 , Larva/drug effects , Larva/growth & development , Male , Phenotype
5.
Nutrients ; 11(4)2019 Apr 19.
Article in English | MEDLINE | ID: mdl-31010128

ABSTRACT

Beer, the most popular beverage containing hops, is also frequently consumed by cancer patients. Moreover, non-alcoholic beer, owing to its nutritional value and high content of biological active compounds, is sometimes recommended to patients by oncologists. However, the potential benefits and negatives have to date not been sufficiently evaluated. The present study was designed to examine the effects of four main hop-derived prenylflavonoids on the viability, reactive oxygen species (ROS) formation, activity of caspases, and efficiency of the chemotherapeutics 5-fluorouracil (5-FU), oxaliplatin (OxPt) and irinotecan (IRI) in colorectal cancer cell lines SW480, SW620 and CaCo-2. All the prenylflavonoids exerted substantial antiproliferative effects in all cell lines, with xanthohumol being the most effective (IC50 ranging from 3.6 to 7.3 µM). Isoxanthohumol increased ROS formation and the activity of caspases-3/7, but 6-prenylnaringenin and 8-prenylnaringenin exerted antioxidant properties. As 6-prenylnaringenin acted synergistically with IRI, its potential in combination therapy deserves further study. However, other prenylflavonoids acted antagonistically with all chemotherapeutics at least in one cell line. Therefore, consumption of beer during chemotherapy with 5-FU, OxPt and IRI should be avoided, as the prenylflavonoids in beer could decrease the efficacy of the treatment.


Subject(s)
Antineoplastic Agents/therapeutic use , Beer , Colorectal Neoplasms/drug therapy , Drug Interactions , Flavonoids/therapeutic use , Humulus/chemistry , Plant Extracts/therapeutic use , Antineoplastic Agents/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Antineoplastic Agents, Phytogenic/therapeutic use , Antioxidants , Beer/adverse effects , Caco-2 Cells , Caspases/metabolism , Cell Line, Tumor , Colorectal Neoplasms/metabolism , Drug Combinations , Feeding Behavior , Flavanones/pharmacology , Flavanones/therapeutic use , Flavonoids/pharmacology , Fluorouracil/therapeutic use , Humans , Irinotecan/therapeutic use , Oxaliplatin/therapeutic use , Plant Extracts/pharmacology , Propiophenones/pharmacology , Propiophenones/therapeutic use , Reactive Oxygen Species/metabolism , Treatment Outcome , Xanthones/pharmacology , Xanthones/therapeutic use
6.
Xenobiotica ; 48(11): 1089-1097, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29098926

ABSTRACT

1. Sesquiterpenes, constituents of plant essential oil, are popular bioactive compounds due to the positive effect on human health, but their potential toxicity and possible herb-drug interactions are often omitted. In our in vivo study, we followed up the effect of p.o. administration of two sesquiterpenes ß-caryophyllene oxide (CAO) and trans-nerolidol (NER) on various xenobiotic-metabolizing enzymes in mice liver and small intestine. 2. To spot the early effect of studied compounds, enzymatic activity and mRNA levels were assessed 6 and 24 h after single dose. 3. CAO and NER markedly increased cytochromes P450 (CYP2B, 3A, 2C) activity and mRNA levels in both tissues. Liver also showed elevated activity of aldo-ketoreductase 1C and carbonyl reductase after treatment. Contrary, sesquiterpenes decreased NAD(P)H:quinone oxidoreductase 1 activity in small intestine. Among conjugation enzymes, only liver sulfotransferase activity was increased by sesquiterpenes. 4. Our results document that single dose of sesquiterpenes modulate activities and expression of several xenobiotic-metabolizing enzymes.


Subject(s)
Enzymes/metabolism , Inactivation, Metabolic/drug effects , Sesquiterpenes/pharmacology , Aldehyde Reductase/metabolism , Animals , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Estradiol Dehydrogenases/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Intestine, Small/drug effects , Intestine, Small/enzymology , Liver/drug effects , Liver/enzymology , Male , Mice, Inbred Strains , NAD(P)H Dehydrogenase (Quinone)/metabolism , Polycyclic Sesquiterpenes , Sesquiterpenes/toxicity
7.
Arch Toxicol ; 92(1): 1-13, 2018 01.
Article in English | MEDLINE | ID: mdl-28905185

ABSTRACT

Public interest in natural therapies has increased significantly over past decades. Herbs and herbal products are extensively consumed worldwide and they are generally considered as safe. However, this may not always be true as many cases of herb-induced liver injury are reported every year. The liver is a frequent target tissue of toxicity from all classes of toxicants as liver structure and function predispose it to high sensitivity to xenobiotics. The present review is focused on the hepatotoxic properties of monoterpenes and sesquiterpenes, plant secondary metabolites that represent the major components of essential oils wildly used in folk medicines, pharmaceutical industry and cosmetics. Most of these terpenes easily enter the human body by oral absorption, penetration through the skin, or inhalation leading to measurable blood concentrations. Several studies showed that some monoterpenes (e.g., pulegone, menthofuran, camphor, and limonene) and sesquiterpenes (e.g., zederone, germacrone) exhibited liver toxicity, which is mainly based on reactive metabolites formation, increased concentration of reactive oxygen species and impaired antioxidant defense. There is a high probability that many other terpenes, without sufficiently known metabolism and effects in human liver, could also exert hepatotoxicity. Especially terpenes, that are important components of essential oils with proved hepatotoxicity, should deserve more attention. Intensive research in terpenes metabolism and toxicity represent the only way to reduce the risk of liver injury induced by essential oils and other terpenes-containing products.


Subject(s)
Chemical and Drug Induced Liver Injury/etiology , Monoterpenes/toxicity , Plants/chemistry , Sesquiterpenes/toxicity , Animals , Humans , Liver/drug effects , Liver/metabolism , Monoterpenes/chemistry , Oils, Volatile/chemistry , Oils, Volatile/toxicity , Plants/metabolism , Reactive Oxygen Species/metabolism , Sesquiterpenes/chemistry
8.
Chem Biol Interact ; 278: 123-128, 2017 Dec 25.
Article in English | MEDLINE | ID: mdl-29074051

ABSTRACT

Sesquiterpenes, the main components of plant essential oils, are often taken in the form of folk medicines and dietary supplements. Several sesquiterpenes possess interesting biological activities but they could interact with concurrently administered drugs via inhibition of drug-metabolizing enzymes. Therefore, the present study was designed to test the potential inhibitory effect of tree structurally relative sesquiterpenes ß-caryophyllene (CAR), ß-caryophyllene oxide (CAO) and α-humulene (HUM) on the activities of the main drug-metabolizing enzymes. For this purpose, rat and human hepatic subcellular fractions were incubated with CAR, CAO or HUM together with specific substrates for oxidation, reduction and conjugation enzymes and their coenzymes. HPLC, spectrophotometric and spectrofluorimetric analyses of product formations were used. All tested sesquiterpenes significantly inhibited cytochromes P4503A (CYP3A) activities in rats as well as in human hepatic microsomes, with CAO being the strongest inhibitor. A non-competitive type of inhibition was found. On the other hand, none of the tested sesquiterpenes significantly affected the activities of carbonyl-reducing enzymes (CBR1, AKRs, NQO1) or conjugation enzymes (UGTs, GSTs, SULTs, COMT). As CYP3A enzymes metabolize many drugs, their inhibition by CAO, CAR and HUM might affect the pharmacokinetics of concurrently administered drugs. Similar results obtained in rat and human hepatic microsomes indicate that rats could be used for further testing of possible drug-sesquiterpenes interactions in vivo.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/metabolism , Cytochrome P-450 CYP3A/metabolism , Microsomes, Liver/enzymology , Sesquiterpenes/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Cytochrome P-450 CYP1A2/chemistry , Cytochrome P-450 CYP1A2/metabolism , Cytochrome P-450 CYP3A/chemistry , Humans , Inhibitory Concentration 50 , Kinetics , Liver/enzymology , Male , Monocyclic Sesquiterpenes , Polycyclic Sesquiterpenes , Rats , Rats, Wistar , Sesquiterpenes/chemistry
9.
Biomed Pharmacother ; 95: 828-836, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28903178

ABSTRACT

BACKGROUND: One approach to improve effect of chemotherapy is combination of classical cytostatic drugs with natural compounds, e. g. sesquiterpenes. In our previous study, sesquiterpenes ß-caryophyllene oxide (CAO) and trans-nerolidol (NER) improved the anti-proliferative effect of doxorubicin (DOX) in intestinal cancer cell lines. PURPOSE: The present study was designed to evaluate the effect of CAO and NER on DOX efficacy, focusing on cell proliferation, migration, apoptosis and DOX accumulation in breast cancer cells MDA-MB-231 and MCF7 in vitro and in mice bearing solid Ehrlich tumors (EST) in vivo. METHODS: The impact of cytotoxic effect was assessed by the neutral red uptake test. The ability to migrate was tested using real-time measurement in x-CELLigence system. Expressions of molecules were examined using western blot analysis. The accumulation of DOX inside the cells using time lapse microscopy was observed. The mice with inoculated EST cells were treated repeatedly with DOX and DOX+CAO or DOX+NER and the growth of tumors were monitored. DOX concentrations in plasma and tumor were assayed using HPLC. RESULTS: In MDA-MB-231, combination of DOX with CAO enhanced anti-proliferative effect and acted strongly synergistic. NER increased accumulation of DOX inside the cells; moreover combination DOX with NER suppressed migration ability in vitro. In vivo, apoptosis was activated especially in group treated with DOX and CAO. However, none of tested sesquiterpenes was able to improve DOX accumulation in tumors and DOX-mediated inhibition of tumor growth. CONCLUSION: In conclusion, sesquiterpenes CAO and NER increased the efficacy of DOX in breast cancer cells in vitro, but did not improve its effect in vivo, in Ehrlich solid tumor bearing mice.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Doxorubicin/therapeutic use , Mammary Neoplasms, Animal/drug therapy , Mammary Neoplasms, Animal/pathology , Sesquiterpenes/therapeutic use , Animals , Breast Neoplasms/blood , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Doxorubicin/blood , Female , Humans , Inhibitory Concentration 50 , Mice , Polycyclic Sesquiterpenes , Sesquiterpenes/chemistry , Sesquiterpenes/pharmacology , Treatment Outcome
10.
Molecules ; 22(4)2017 Mar 24.
Article in English | MEDLINE | ID: mdl-28338641

ABSTRACT

Sesquiterpenes, 15-carbon compounds formed from three isoprenoid units, are the main components of plant essential oils. Sesquiterpenes occur in human food, but they are principally taken as components of many folk medicines and dietary supplements. The aim of our study was to test and compare the potential inhibitory effect of acyclic sesquiterpenes, trans-nerolidol, cis-nerolidol and farnesol, on the activities of the main xenobiotic-metabolizing enzymes in rat and human liver in vitro. Rat and human subcellular fractions, relatively specific substrates, corresponding coenzymes and HPLC, spectrophotometric or spectrofluorometric analysis of product formation were used. The results showed significant inhibition of cytochromes P450 (namely CYP1A, CYP2B and CYP3A subfamilies) activities by all tested sesquiterpenes in rat as well as in human hepatic microsomes. On the other hand, all tested sesquiterpenes did not significantly affect the activities of carbonyl-reducing enzymes and conjugation enzymes. The results indicate that acyclic sesquiterpenes might affect CYP1A, CYP2B and CYP3A mediated metabolism of concurrently administered drugs and other xenobiotics. The possible drug-sesquiterpene interactions should be verified in in vivo experiments.


Subject(s)
Cytochrome P-450 Enzyme Inhibitors/pharmacology , Cytochrome P-450 Enzyme System/metabolism , Farnesol/pharmacology , Liver/enzymology , Sesquiterpenes/pharmacology , Xenobiotics/metabolism , Animals , Cytochrome P-450 Enzyme Inhibitors/chemistry , Farnesol/chemistry , Humans , Inhibitory Concentration 50 , Kinetics , Rats , Sesquiterpenes/chemistry , Subcellular Fractions/enzymology
11.
Molecules ; 21(9)2016 Sep 07.
Article in English | MEDLINE | ID: mdl-27617982

ABSTRACT

The knowledge of processes in intestinal cells is essential, as most xenobiotics come into contact with the small intestine first. Caco-2 cells are human colorectal adenocarcinoma that once differentiated, exhibit enterocyte-like characteristics. Our study compares activities and expressions of important conjugation enzymes and their modulation by green tea extract (GTE) and epigallocatechin gallate (EGCG) using both proliferating (P) and differentiated (D) caco-2 cells. The mRNA levels of the main conjugation enzymes were significantly elevated after the differentiation of Caco-2 cells. However, no increase in conjugation enzymes' activities in differentiated cells was detected in comparison to proliferating ones. GTE/EGCG treatment did not affect the mRNA levels of any of the conjugation enzymes tested in either type of cells. Concerning conjugation enzymes activities, GTE/EGCG treatment elevated glutathione S-transferase (GST) activity by approx. 30% and inhibited catechol-O-methyltransferase (COMT) activity by approx. 20% in differentiated cells. On the other hand, GTE as well as EGCG treatment did not significantly affect the activities of conjugation enzymes in proliferating cells. Administration of GTE/EGCG mediated only mild changes of GST and COMT activities in enterocyte-like cells, indicating a low risk of GTE/EGCG interactions with concomitantly administered drugs. However, a considerable chemo-protective effect of GTE via the pronounced induction of detoxifying enzymes cannot be expected as well.


Subject(s)
Catechin/analogs & derivatives , Catechol O-Methyltransferase/biosynthesis , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Glutathione Transferase/biosynthesis , Caco-2 Cells , Catechin/chemistry , Catechin/pharmacology , Humans , RNA, Messenger/biosynthesis , Tea/chemistry
12.
Planta Med ; 82(1-2): 89-96, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26485638

ABSTRACT

Essential oil from the leaves of Myrica rubra, a subtropical Asian fruit tree traditionally used in folk medicines, has a significant antiproliferative effect in several intestinal cancer cell lines. Doxorubicin belongs to the most important cytostatics used in cancer therapy. The present study was designed to evaluate the effects of defined essential oil from M. rubra leaves on efficacy, prooxidative effect, and accumulation of doxorubicin in cancer cell lines and in non-cancerous cells. For this purpose, intestinal adenocarcinoma CaCo2 cells were used. Human fibroblasts (periodontal ligament) and a primary culture of rat hepatocytes served as models of non-cancerous cells. The results showed that the sole essential oil from M. rubra has a strong prooxidative effect in cancer cells while it acts as a mild antioxidant in hepatocytes. Combined with doxorubicin, the essential oil enhanced the antiproliferative and prooxidative effects of doxorubicin in cancer cells. At higher concentrations, synergism of doxorubicin and essential oil from M. rubra was proved. In non-cancerous cells, the essential oil did not affect the toxicity of doxorubicin and the doxorubicin-mediated reactive oxygen species formation. The essential oil increased the intracellular concentration of doxorubicin and enhanced selectively the doxorubicin accumulation in nuclei of cancer cells. Taken together, essential oil from M. rubra leaves could be able to improve the doxorubicin efficacy in cancer cells due to an increased reactive oxygen species production, and the doxorubicin accumulation in nuclei of cancer cells.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Doxorubicin/pharmacology , Myrica/chemistry , Oils, Volatile/pharmacology , Plant Extracts/pharmacology , Animals , Caco-2 Cells , Cell Proliferation/drug effects , Cells, Cultured , Drug Synergism , Hepatocytes/drug effects , Humans , Intestinal Neoplasms , Male , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
13.
Eur J Nutr ; 55(1): 361-71, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25663641

ABSTRACT

PURPOSE: Consumption of dietary supplements with green tea extract (GTE) is popular for weight management, but it may be accompanied by various side effects, including interactions with drugs. The aim of the present in vivo study was to evaluate the effect of defined GTE (Polyphenon 60) in three dosage schemes on insulin, leptin and drug-metabolizing enzymes in obese mice. METHODS: Experimental obesity was induced by repeated s.c. application of monosodium glutamate to newborn mice. Green tea extract was administered in three dosage schemes in chow diet. The plasmatic levels of insulin and leptin were assayed using enzyme-linked immunosorbent assay. Enzyme activities and mRNA expressions of drug-metabolizing enzymes (totally 13) were analyzed in liver and small intestine using spectrophotometric and HPLC assays and RT-PCR, respectively. RESULTS: GTE-treatment decreased insulin and leptin levels. Eleven enzymes were significantly affected by GTE-treatment. Long-term administration of 0.01% GTE caused increase in the activity and mRNA level of cytochrome P450 3A4 (CYP3A4) ortholog in the liver as well as in the small intestine. Interestingly, short-term overdose by GTE (0.1%) had more pronounced effects on enzyme activities and mRNA expressions than long-term overdose. CONCLUSIONS: GTE-mediated induction of CYP3A4 ortholog, the main drug-metabolizing enzyme, could result in decreased efficacy of simultaneously or subsequently administered drug in obese individuals.


Subject(s)
Dietary Supplements , Obesity/drug therapy , Plant Extracts/pharmacology , Tea/chemistry , Animals , Antioxidants/pharmacology , Aryl Hydrocarbon Hydroxylases/genetics , Aryl Hydrocarbon Hydroxylases/metabolism , Cytochrome P-450 CYP2E1/genetics , Cytochrome P-450 CYP2E1/metabolism , Cytochrome P-450 CYP3A/genetics , Cytochrome P-450 CYP3A/metabolism , Cytochrome P450 Family 2 , Disease Models, Animal , Dose-Response Relationship, Drug , Enzyme-Linked Immunosorbent Assay , Insulin/blood , Leptin/blood , Liver/drug effects , Liver/metabolism , Male , Mice , Mice, Obese , Obesity/chemically induced , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sodium Glutamate/adverse effects
14.
Drug Metab Rev ; 47(4): 520-33, 2015.
Article in English | MEDLINE | ID: mdl-26415702

ABSTRACT

Carbonyl reductase 1 (CBR1), an enzyme belonging to the short-chain dehydrogenases/reductases family, has been detected in all human tissues. CBR1 catalyzes the reduction of many xenobiotics, including important drugs (e.g. anthracyclines, nabumetone, bupropion, dolasetron) and harmful carbonyls and quinones. Moreover, it participates in the metabolism of a number of endogenous compounds and it may play a role in certain pathologies. Plant polyphenols are not only present in many human food sources, but are also a component of many popular dietary supplements and herbal medicines. Many studies reviewed herein have demonstrated the potency of certain flavonoids, stilbenes and curcuminoids in the inhibition of the activity of CBR1. Interactions of these polyphenols with transcriptional factors, which regulate CBR1 expression, have also been reported in several studies. As CBR1 plays an important role in drug metabolism as well as in the protection of the organism against potentially harmful carbonyls, the modulation of its expression/activity may have significant pharmacological and/or toxicological consequences. Some polyphenols (e.g. luteolin, apigenin and curcumin) have been shown to be very potent CBR1 inhibitors. The inhibition of CBR1 seems useful regarding the increased efficacy of anthracycline therapy, but it may cause the worse detoxification of reactive carbonyls. Nevertheless, all known information about the interactions of polyphenols with CBR1 have only been based on the results of in vitro studies. With respect to the high importance of CBR1 and the frequent consumption of polyphenols, in vivo studies would be very helpful for the evaluation of risks/benefits of polyphenol interactions with CBR1.


Subject(s)
Alcohol Oxidoreductases/antagonists & inhibitors , Alcohol Oxidoreductases/metabolism , Polyphenols/pharmacology , Alcohol Oxidoreductases/biosynthesis , Alcohol Oxidoreductases/genetics , Animals , Bupropion/metabolism , Butanones/metabolism , Butyrophenones/metabolism , Daunorubicin/metabolism , Doxorubicin/metabolism , Gene Expression Regulation, Enzymologic , Haloperidol/metabolism , Humans , Indoles/metabolism , Nabumetone , Neoplasms/enzymology , Phenylpropionates/metabolism , Quinolizines/metabolism , Substrate Specificity , Xenobiotics/metabolism
15.
Nutr Res ; 35(10): 901-909, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26319613

ABSTRACT

Consumption of antioxidant-enriched diets is 1 method of addressing obesity, which is associated with chronic oxidative stress and changes in the activity/expression of various enzymes. In this study, we hypothesized that the modulation of antioxidant enzymes and redox status through a cranberry extract (CBE)-enriched diet would differ between obese and nonobese mice. The CBE used in this study was obtained from the American cranberry (Vaccinium macrocarpon, Ericaceae), a popular constituent of dietary supplements that is a particularly rich source of (poly)phenols and has strong antioxidant properties. The present study was designed to test and compare the in vivo effects of 28-day consumption of a CBE-enriched diet (2%) on the antioxidant status of nonobese mice and mice with monosodium glutamate-induced obesity. Plasma, erythrocytes, liver, and small intestine were studied concurrently to obtain more complex information. The specific activities, protein, and messenger RNA expression levels of antioxidant enzymes as well as the levels of malondialdehyde and thiol (SH) groups were analyzed. Cranberry extract treatment increased the SH group content in plasma and the glutathione S-transferase activity in the erythrocytes of the obese and nonobese mice. In addition, in the obese animals, the CBE treatment reduced the malondialdehyde content in erythrocytes and increased NAD(P)H: quinone oxidoreductase (liver) and catalase (erythrocytes and small intestine) activities. The elevation of hepatic NAD(P)H: quinone oxidoreductase activity was accompanied by an increase in the corresponding messenger RNA levels. The effects of CBE on the activity of antioxidant enzymes and redox status were more pronounced in the obese mice compared with the nonobese mice.


Subject(s)
Catalase/metabolism , Fruit/chemistry , NAD(P)H Dehydrogenase (Quinone)/metabolism , Obesity/enzymology , Plant Extracts/administration & dosage , Vaccinium macrocarpon , Animals , Antioxidants/administration & dosage , Catalase/blood , Diet , Erythrocytes/chemistry , Glutathione Transferase/blood , Intestine, Small/enzymology , Liver/enzymology , Malondialdehyde/blood , Mice , NAD(P)H Dehydrogenase (Quinone)/genetics , Obesity/blood , Obesity/chemically induced , Oxidation-Reduction , RNA, Messenger/analysis , Sulfhydryl Compounds/blood
16.
Acta Pharm ; 65(1): 65-73, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25781705

ABSTRACT

Green tea is a favorite beverage and its extracts are popular components of dietary supplements. The aim of the present in vivo study was to obtain detailed information about the effect of a standard green tea extract (Polyphenon, P), at different doses, on antioxidant enzymes and oxidative stress markers in murine blood, liver, small and large intestine. In all doses, P improved the oxidative stress status via an increased content of plasmatic SH-groups (by 21-67 %). Regarding antioxidant enzymes in tissues, the low dose of P had the best positive effect as it elevated the activity of NADPH quinone reductase in liver and small intestine, thioredoxin reductase in small intestine and hepatic superoxide dismutase. Based on these facts, consumption of green tea seems to be safe and beneficial, while consumption of dietary supplements containing high doses of catechins may disturb oxidative balance by lowering the activity of thioredoxin reductase, glutathione S-transferase, glutathione reductase and superoxide dismutase.


Subject(s)
Antioxidants/metabolism , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Tea/chemistry , Administration, Oral , Animals , Dietary Supplements , Dose-Response Relationship, Drug , Male , Mice , NAD(P)H Dehydrogenase (Quinone)/metabolism , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification
17.
Curr Top Med Chem ; 14(22): 2478-94, 2014.
Article in English | MEDLINE | ID: mdl-25478887

ABSTRACT

Sesquiterpenes, 15-carbon compounds formed from 3 isoprenoid units, are secondary metabolites produced mainly in higher plants but also in fungi and invertebrates. Sesquiterpenes occur in human food, but they are principally taken as components of many folk medicines and dietary supplements. Moreover, sesquiterpenes could become a rich reservoir of candidate compounds for drug discovery as several sesquiterpenes and their derivatives possess interesting biological activities. Recent efforts in the research and development of new drugs derived from natural products have led to the identification of a variety of sesquiterpenes that possess promising anti-inflammatory, antiparasitic and anti-carcinogenic activities. On the other hand, some sesquiterpenes can cause serious toxicity and other adverse effects. Therefore, more and more attention has been paid to the investigation of the mechanisms of biological activities of sesquiterpenes in vitro as well as in vivo. The data collected in this review show that many of sesquiterpenes biological activities are based on antioxidant or pro-oxidant actions of sesquiterpenes. Structure, concentration, metabolism as well as type of cells determine if sesquiterpene acts as anti-oxidant or pro-oxidant. Therefore, detailed research of sesquiterpenes is very important for evaluation of their efficacy and for their safe use.


Subject(s)
Antioxidants/metabolism , Sesquiterpenes/metabolism , Antioxidants/chemistry , Molecular Structure , Oxidation-Reduction , Sesquiterpenes/chemistry
18.
Molecules ; 19(9): 14948-60, 2014 Sep 18.
Article in English | MEDLINE | ID: mdl-25237750

ABSTRACT

The use of dietary supplements containing cranberry extract is a common way to prevent urinary tract infections. As consumption of these supplements containing a mixture of concentrated anthocyanins and proanthocyanidins has increased, interest in their possible interactions with drug-metabolizing enzymes has grown. In this in vivo study, rats were treated with a standardized cranberry extract (CystiCran®) obtained from Vaccinium macrocarpon in two dosage schemes (14 days, 0.5 mg of proanthocyanidins/kg/day; 1 day, 1.5 mg of proanthocyanidins/kg/day). The aim of this study was to evaluate the effect of anthocyanins and proanthocyanidins contained in this extract on the activity and expression of intestinal and hepatic biotransformation enzymes: cytochrome P450 (CYP1A1, CYP1A2, CYP2B and CYP3A), carbonyl reductase 1 (CBR1), glutathione-S-transferase (GST) and UDP-glucuronosyl transferase (UGT). Administration of cranberry extract led to moderate increases in the activities of hepatic CYP3A (by 34%), CYP1A1 (by 38%), UGT (by 40%), CBR1 (by 17%) and GST (by 13%), while activities of these enzymes in the small intestine were unchanged. No changes in the relative amounts of these proteins were found. Taken together, the interactions of cranberry extract with simultaneously administered drugs seem not to be serious.


Subject(s)
Intestines/drug effects , Liver/drug effects , Plant Extracts/pharmacology , Vaccinium macrocarpon/chemistry , Animals , Biotransformation , Intestines/enzymology , Liver/enzymology , Male , Rats , Rats, Wistar
19.
Pak J Pharm Sci ; 27(1): 103-6, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24374437

ABSTRACT

The aim of this study was to evaluate in vitro anti-proliferative (tested on MCF-7, MDA-MB-231, and MCF-10A cell lines) and anti-inflammatory (evaluated as inhibition of prostaglandin E2 synthesis catalyzed by cyclooxygenase-2) effect of various extracts from Vaccinium bracteatum leaves and fruits. The highest anti-proliferative effect possessed leaf dichloromethane extract with IC50 values ranging from 93 to 198 µg/mL. In the case of cyclooxygenase-2 inhibition, n-hexane, dichloromethane, and ethanol fruit extracts showed the best activity with IC50 values = 2.0, 5.4, and 12.7 µg/mL, respectively. These results indicate that V. bracteatum leaves and fruits could be useful source of anti-cancer and anti-inflammatory compounds.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Plant Extracts/pharmacology , Vaccinium , Cell Line, Tumor , Cell Proliferation/drug effects , Fruit , Humans , Plant Leaves
20.
Drug Metab Rev ; 44(4): 267-86, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22998389

ABSTRACT

Many studies reviewed herein demonstrated the potency of some flavonoids to modulate the activity and/or expression of glutathione S-transferases (GSTs). Because GSTs play a crucial role in the detoxification of xenobiotics, their inhibition or induction may significantly affect metabolism and biological effects of many drugs, industrials, and environmental contaminants. The effect of flavonoids on GSTs strongly depends on flavonoid structure, concentration, period of administration, as well as on GST isoform and origin. Moreover, the results obtained in vitro are often contrary to the vivo results. Based on these facts, the revelation of important flavonoid-drug or flavonoid-pollutant interaction has been complicated. However, it should be borne in mind that ingestion of certain flavonoids in combination with drugs or pollutants (e.g., acetaminophen, simvastatin, cyclophosphamide, cisplatine, polycyclic aromatic hydrocarbons, chlorpyrifos, acrylamide, and isocyanates), which are GST substrates, could have significant pharmacological and toxicological consequences. Although reasonable consumptions of a flavonoids-rich diet (that may lead to GST induction) are mostly beneficial, the uncontrolled intake of high concentrations of certain flavonoids (e.g., quercetin and catechins) in dietary supplements (that may cause GST inhibition) may threaten human health.


Subject(s)
Antioxidants/metabolism , Dietary Supplements , Flavonoids/metabolism , Glutathione Transferase/biosynthesis , Animals , Antioxidants/adverse effects , Antioxidants/therapeutic use , Biotransformation , Dietary Supplements/adverse effects , Enzyme Induction , Enzyme Inhibitors/adverse effects , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/therapeutic use , Flavonoids/adverse effects , Flavonoids/therapeutic use , Food-Drug Interactions , Glutathione Transferase/antagonists & inhibitors , Glutathione Transferase/chemistry , Glutathione Transferase/metabolism , Humans , Liver/drug effects , Liver/enzymology , Liver/metabolism , Xenobiotics/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL